ArticlePloS one2023
Luxeptinib interferes with LYN-mediated activation of SYK and modulates BCR signaling in lymphoma.
Himangshu Sonowal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticlePloS one2023
Himangshu Sonowal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.